Via S. Antonio, 12
Research, discovery and development of new therapies are key activities to respond to the health needs of the people and critical processes for the economic and social development of the country.
Despite low investments, the quality of Italian scientific research is outstanding, achieving excellence in many instances. However, only in very few cases this research translates into industrial development, employment and GDP growth for our country.
The Conference “Which Future for Drug Research & Development in Lombardy?” stems from the opportunity to promote a transformational change in drug discovery and clinical trials in Lombardy.
Major aim of this Conference is to gather operational proposals and recommendations for the development to be submitted to the institutions. That will allow institutions to take the necessary steps for an effective change in a
strategic sector for the development of people, society, the economy.
This initiative is preceded by two Workshops (respectively on Drug Discovery and Clinical Trial) and the preparation of a Draft 2014 Report on Clinical Trials in Lombardy. It is then followed first by focused meetings on relevant topics discussed at the Conference, then by the issue of the Conference Proposal Document.
Presentation of the Proposal Document and discussion on its implementation with relevant Institutions will conclude the activities of the Conference.
Con riferimento alla iniziativa promossa dalla Presidenza della Regione Toscana: “per rilanciare attività ed investimenti delle aziende farmaceutiche, della diagnostica e dei dispositivi medici, proponendo la Toscana come un territorio pilota anche in chiave nazionale“, si può trovare il programma e la lettera di invito pubblicamente disponibili (allegati 1 e 2).
Ulteriori Informazioni sono disponibili presso il “Settore Politiche Regionali per l’attrazione degli investimenti”.
Si segnala che il 23 settembre il Gruppo Chiesi ha annunciato la creazione del proprio fondo di Venture Capital, Chiesi Ventures http://www.chiesiventures.com/ , con l’obiettivo di complementare l’interesse strategico del Gruppo Chiesi nell’area delle malattie rare, investendo in opportunità in sviluppo iniziale ed espandendo la rete di contatti Chiesi negli Stati Uniti presso istituzioni accademiche, investitori nel mondo del Venture Capital, organizzazioni di pazienti e ‘start-up’ impegnate nello sviluppo di terapie per malattie rare. Chiesi Ventures ha uffici a Boston, Massachusetts, nel Research Triangle Park, North Carolina e a Parma, Italia e investirà in opportunità provenienti dagli Stati Uniti e dall’Europa.
Video
- 26.09.2014 – Which future for drug research… – Intervista Dott.Paleari
- 26.09.2014 – Which future for drug research… – Intervista Dott.Melazzini
- 26.09.2014 – Which future for drug research… – Intervista Prof.Garattini
- 26.09.2014 – Which future for drug research… – Intervista Dott.Corti
- 26.09.2014 – Which future for drug research… – Intervista Prof.Centanni
- 26.09.2014 – Which future for drug research… – Intervento integrale Pasinelli
- 26.09.2014 – Which future for drug research… – Intervento Corti
- 26.09.2014 – Which future for drug research… – Intervento Holmes
- 26.09.2014 – Which future for drug research… – Intervento Paleari
- 26.09.2014 – Which future for drug research… – Intervento Santus
- 26.09.2014 – Which future for drug research… – Intervento Blasi
- 26.09.2014 – Which future for drug research… – Intervento Melazzini
- 26.09.2014 – Which future for drug research… – Intervento Chendi
- 26.09.2014 – Which future for drug research… Prima tavola rotonda
Links
Allegati
- Programma del convegno (pdf – 247 KB )
Materiali da consultare
- Breathing new life into pharma’s innovation engine (pdf – 62.3 KB )
- Libro bianco sullo sviluppo del sistema sociosanitario in Lombardia (pdf – 4.78 MB )
- Germano Carganico: Istituzioni e innovazione, quale ruolo per lo sviluppo economico? L’esperienza della Regione Toscana (pdf – 280 KB )
- Domande e risposte sulla consultazione pubblica sull’implementazione dei requisiti di trasparenza del Regolamento europeo sui Clinical Trial (pdf – 131 KB )
- Toscana Pharma & Devices Valley – Workshop di avvio – Invito (pdf – 544 KB )
- Toscana Pharma & Devices Valley – Workshop di avvio – Programma e locandina (pdf – 339 KB )
- Sharing Clinical Trial Data: Maximizing Benefits, Minimizing Risk (pdf – 4.67 MB )
- European Medicines Agency policy on publication of clinical data for medicinal products for human use (pdf – 232 KB )
- Questions and answers on the European Medicines Agency policy on publication of clinical data for medicinal products for human use (pdf – 171 KB )
Relazioni presentate
- Antonella d’Arminio Monforte: How to close the gap? (pdf – 239 KB )
- Federica Draghi: How to close the gap? (pdf – 1.00 MB )
- Antonella Isacchi: How to close the gap? (pdf – 285 KB )
- Gaia S Panina: Development of New Therapies and Clinical Trials in Lombardy Region How to Close the Gap (pdf – 564 KB )
- Francesca Pasinelli: Discovery of advanced therapy medicinal products: The Telethon model (pdf – 780 KB )
- Renato Ridella: How to close the gap? (pdf – 270 KB )
- Alessandro Sidoli: How to close the gap? (pdf – 858 KB )
- Duncan Holmes: R&D Strategy Bridging the academia-industry gap (pdf – 3.23 MB )
- Maria P. Abbracchio: Round Table:How to close the gap? (pdf – 247 KB )
- Germano Carganico: Istituzioni e innovazione, quale ruolo per lo sviluppo economico? L’esperienza della Regione Toscana (pdf – 280 KB )
- Mariapia Cirenei: How to close the gap (pdf – 388 KB )